Exploring GLP-1 Impacts on Alzheimer’s and Diabetes Management

This chapter discusses the impact of drugs like samaglitide and terzepatide on type 2 diabetes, obesity, and their possible connections to Alzheimer's Disease. It also highlights Eli Lilly's role in the release of these medications and their sponsorship of Olympic events, underlining the importance of these developments in public health.